InvestorsHub Logo
Followers 12
Posts 1099
Boards Moderated 0
Alias Born 06/07/2018

Re: TR6767 post# 63286

Thursday, 12/26/2019 8:15:10 PM

Thursday, December 26, 2019 8:15:10 PM

Post# of 83046
You've got your catalysts partially right, but there is something you're missing. States like NY, TX, and OK (and others) are allowing for the sale of CBD products with or without FDA guidance. This guarantees sales in those states, you see. With guaranteed sales = guaranteed revenue. As more and more states guarantee retailers safe harbor by allowing for the sale of safe CBD products, the issue of an FDA pathway will become more and more irrelevant. States have been deciding on their own whether or not to advance, and they don't seem to be waiting around for FDA.

Also, the CDC just vindicated legitimate CBD and THC vape products with their latest update on the issue.

Hemp banking is no longer a big issue with new federal guidance.

Chase and Deutsche Banks are starting cannabis funds worth over $2 billion.

My friend, let me tell you another catalyst. Tax loss harvesting the cannabis industry during a record DOW became commonplace due to the tax-minimizing incentives from awesome DOW gains. This ends in a few days.

Short borrowing rates are increasing in the cannabis sector, and shorts are getting owned by the DOW. This will lead to a flood of covering.

Nielsen made a conservative estimate by saying that the CBD sector would be worth nearly $3 billion by the end of 2020.

Trust me, there's plenty to get excited about for 2020.